I’m a researcher deeply interested in aging/longevity biotech. My goal is to directly contribute to the R&D and operations that will add healthy years to everyone’s life by bringing longevity drugs to the market.
I was the Director of Research & Operations at the San Francisco-based startup NeuroAge Therapeutics, where I led early target validation efforts and then oversaw operations related to the consumer-facing NeuroAge Test.
Before that, I completed my PhD in Biology of Aging in the Campisi Lab at the Buck Institute for Research on Aging. There, I worked on cellular senescence, an established hallmark of aging. I developed a high-throughput method to measure senescence burden and identified sub-populations of senescent cells with different sensitivity to senolytic treatment.